… drug (IND) application to test RPT1G in a Phase 1 … present results from the Phase 1 healthy volunteer study, … clinical trials, and the potential for seven years of market exclusivity following drug … treatment. About the Phase 1 Healthy Volunteer Study RPT1G …

… related AEs were reported. Phase I/II efficacy results: … 20/20 vision). Phase I/II safety results: … randomized, double-masked, controlled clinical trial evaluating the safety and … phase III clinical trials, 505(b)(2) New Drug Application (NDA …

… before they move to Phase I trials. Advertisement Advertisement In … “a paradigm shift in drug evaluation” that could accelerate … River Laboratories, previously told Clinical Trials Arena that the sector … cancer cells to predict drug resistance mechanisms and …

… dosed in the SANTANA-225 phase 1/2 study of 225Ac … SANTANA-225 clinical trial (NCT06939036) is a global, open-label phase 1/2 … 2025, 225Ac-SSO110 received Orphan Drug Designation (ODD) from the U … .S. Food and Drug Administration (FDA) for the …

… investigational New Drug (IND) application to initiate a phase 2a clinical trial of … earlier clinical trials. According to the company, the findings of that phase 1 study … Application to Initiate Phase 2a Clinical Trial of JOTROL™ in Parkinson’s …

… completed the U.S. phase 1 clinical trial of its experimental treatment OLX301A … and multiple-dose studies, meeting phase 1 goals. In this trial, … safety profile. No serious drug-related adverse events were … "The U.S. phase 1 trial of OLX301A showed strong …

… dosed in the SANTANA-225 Phase 1/2 study of … SANTANA-225 clinical trial (NCT06939036) is a global, open-label Phase 1/2 … 2025, 225Ac-SSO110 received Orphan Drug Designation (ODD) from the U … currently being investigated in the Phase 1/2 SANTANA-225 …

… Cancer Cases Fuel Clinical Trials: Increasing cancer … Clinical Trial Growth: Increasing investments in oncology drug development further accelerate clinical trials … Phase I … 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹𝘀 𝗺𝗮𝗿𝗸𝗲𝘁? The global oncology clinical trials market was valued at USD …

… data from the ongoing Phase 1 clinical trial of its investigational product … U.S. Food and Drug Administration (FDA). Further … on the investigational new drug (“IND”) applications for … regulatory approvals to conduct clinical trials, including risks related …

… cohort in its ongoing Phase I/IIa clinical trial evaluating CMND-100 for … activated for the Phase I/IIa clinical trial. The multinational, multicenter Phase I/IIa … drinking. Following FDA Investigational New Drug (IND) approval, the trial …